Cargando…

A link between long-term natalizumab dosing in MS and PML: Putting the puzzle together

Detalles Bibliográficos
Autores principales:	Major, Eugene O., Nath, Avindra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853054/ https://www.ncbi.nlm.nih.gov/pubmed/27213175 http://dx.doi.org/10.1212/NXI.0000000000000235

Ejemplares similares

Predicting outcome in abdominal sepsis: putting the puzzle together
por: Reid, Catherine S., et al.
Publicado: (2021)

Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
por: Ryerson, Lana Zhovtis, et al.
Publicado: (2019)

Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
por: Bsteh, Gabriel, et al.
Publicado: (2017)

Targeting Neurohormonal Activation in Pulmonary Arterial Hypertension: Putting the Puzzle Together
por: Gomez-Arroyo, Jose, et al.
Publicado: (2017)

The Pertussis resurgence: putting together the pieces of the puzzle
por: Lapidot, Rotem, et al.
Publicado: (2016)

Immunological Markers for PML Prediction in MS Patients Treated with Natalizumab
por: Antoniol, Caroline, et al.
Publicado: (2015)

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients
por: Dong-Si, Tuan, et al.
Publicado: (2014)

Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
por: Hodecker, Sibylle C., et al.
Publicado: (2017)

Natalizumab-PML survivors with subsequent MS treatment: Clinico-radiologic outcome
por: Maillart, Elisabeth, et al.
Publicado: (2017)

Tuberculous Pericarditis: A Complex Puzzle to Put Together
por: Lazaros, George, et al.
Publicado: (2015)

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Machine perfusion of the liver: Putting the puzzle pieces together
por: Boteon, Yuri L, et al.
Publicado: (2021)

Treatment of natalizumab‐associated PML with filgrastim
por: Stefoski, Dusan, et al.
Publicado: (2019)

New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
por: Toboso, Inmaculada, et al.
Publicado: (2020)

Putting together the psoriasis puzzle: an update on developing targeted therapies
por: Johnson-Huang, Leanne M., et al.
Publicado: (2012)

Exosomes in Prostate Cancer: Putting Together the Pieces of a Puzzle
por: Soekmadji, Carolina, et al.
Publicado: (2013)

Pattern Recognition Receptors and DNA Repair: Starting to Put a Jigsaw Puzzle Together
por: Kutikhin, Anton G., et al.
Publicado: (2014)

Maraviroc in PML-IRIS: A separate ball game under HIV infection and natalizumab?
por: Steiner, Israel, et al.
Publicado: (2017)

Improving risk‐stratification of natalizumab‐associated PML
por: Tugemann, Bastian, et al.
Publicado: (2021)

Michigan Molecular Interactions (MiMI): putting the jigsaw puzzle together
por: Jayapandian, Magesh, et al.
Publicado: (2007)

Cannabinoids for Treating Cardiovascular Disorders: Putting Together a Complex Puzzle
por: Eid, Basma Ghazi
Publicado: (2018)

7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study
por: Sinnecker, Tim, et al.
Publicado: (2015)

Lck activation: puzzling the pieces together
por: Simeoni, Luca
Publicado: (2017)

Putting Together a Global Effort
por: Hong, Joon Pio (Jp)
Publicado: (2017)

Putting Together the Pieces of Polio: How Dorothy Horstmann Helped Solve the Puzzle
por: Carleton, Heather A.
Publicado: (2011)

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle
por: Berruti, Alfredo, et al.
Publicado: (2010)

Recovery after critical illness: putting the puzzle together—a consensus of 29
por: Azoulay, Elie, et al.
Publicado: (2017)

Integrating Transcriptome and Epigenome: Putting Together the Pieces of the Type 2 Diabetes Pathogenesis Puzzle
por: Das, Swapan Kumar
Publicado: (2014)

Concomitant granule cell neuronopathy in patients with natalizumab-associated PML
por: Wijburg, Martijn T., et al.
Publicado: (2016)

PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation
por: Killestein, J., et al.
Publicado: (2014)

Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment
por: Himedan, Mai, et al.
Publicado: (2017)

CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients
por: Lieberman, Linda A., et al.
Publicado: (2016)

Pharmacodynamics of natalizumab extended interval dosing in MS
por: Zhovtis Ryerson, Lana, et al.
Publicado: (2020)

Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities
por: Honce, Justin M., et al.
Publicado: (2015)

Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study
por: Santiago-Setien, Pilar, et al.
Publicado: (2023)

QRS as a Risk Stratification Tool: Putting the Fragments Together
por: Subramanian, Anandaraja
Publicado: (2014)

Management of information within Portuguese families with Huntington disease: a transgenerational process for putting the puzzle together
por: Oliveira, Carla Roma, et al.
Publicado: (2020)

Putting the Puzzle Together To Get the Whole Picture: Molecular Basis of the Affinity of Two Steroid Derivatives to Acetylcholinesterase
por: Richmond, Victoria, et al.
Publicado: (2023)

The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing
por: van Kempen, Zoé LE, et al.
Publicado: (2017)

Sequencing and Analysis of JC Virus DNA From Natalizumab-Treated PML Patients
por: Reid, Carl E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1uit07rgd9c3rmt65u0rgfq81v